Is a Combination of a GnRH Agonist and Recombinant Growth Hormone an Effective Treatment to Increase the Final Adult Height of Girls with Precocious or Early Puberty?

The aim of treatment for idiopathic central precocious puberty (ICPP) is to increase final adult stature, for which gonadotropin-releasing hormone agonist (GnRHa) is the gold standard. Early puberty is frequently similar to ICPP, with pubertal onset only slightly advanced. Short stature may result f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Endocrinol
Autors principals: Song, Wei, Zhao, Fei, Liang, Shuang, Li, Guimei, Xue, Jiang
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332953/
https://ncbi.nlm.nih.gov/pubmed/30693027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1708650
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars